Health & Science in Science & Technology : Practice MCQ Questions & Answers with Explanations

Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age, most commonly occurring in women over 30. It is a cancer of the cervical cells and all women are at risk. According to WHO, approximately 570,000 women were diagnosed with cervical cancer worldwide in 2018; India's first indigenous qHPV vaccine CERVAVAC was developed by the Serum Institute of India in coordination with the Department of Biotechnology.

India launched its first indigenous vaccine for cervical cancer — CERVAVAC, a quadrivalent HPV (qHPV) vaccine — on September 1, 2022, developed by the Serum Institute of India (Pune) in coordination with the Department of Biotechnology. Cervical cancer is the fourth most common cancer in women globally and ranks second among Indian women aged 15–44. WHO estimated 570,000 women were diagnosed with cervical cancer worldwide in 2018.